End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
89,800 KRW | +1.58% | +1.70% | -10.56% |
May. 10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
Business Summary
Number of employees: 252
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drug Development
100.0
%
| 246,179 | 100.0 % | 354,892 | 100.0 % | +44.16% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
143.4
%
| 388,212 | 157.7 % | 508,889 | 143.4 % | +31.09% |
Consolidated Adjustment
-130.9
%
| -356,974 | -145.0 % | -464,702 | -130.9 % | +30.18% |
South Korea
87.5
%
| 214,941 | 87.3 % | 310,705 | 87.5 % | +44.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 22-12-31 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 17-03-15 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Young-Ju Bang
BRD | Director/Board Member | - | 19-08-26 |
Hae-Young Ahn
BRD | Director/Board Member | - | 19-08-26 |
Min-Seop Song
BRD | Director/Board Member | 54 | 19-08-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,313,250 | 27,996,731 ( 35.75 %) | 0 | 35.75 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.56% | 5.13B | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.84% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
+0.07% | 1.59B |
- Stock Market
- Equities
- A326030 Stock
- Company SK Biopharmaceuticals Co., Ltd.